Skip to main content
. 2015 Sep 25;16(10):23279–23299. doi: 10.3390/ijms161023279

Figure 3.

Figure 3

Single-parameter toxicological screening of CdTe QDs in AML12 cells. (A) (3-4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay; and (B) ATP assay. AML12 cells were treated with a wide dose range (21.66 to 118.5 μg/mL) of CdTe QDs for 24 and 48 h, respectively. Data are presented as mean ± standard deviations (SD) of the three representative experiments. The asterisks (*) and indicate statistically significant differences compared to control with p < 0.05.